Liminatus Pharma, Inc. Class A Common Stock
General ticker "LIMN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $150.5M (TTM average)
Liminatus Pharma, Inc. Class A Common Stock does not follow the US Stock Market performance with the rate: -30.0%.
Estimated limits based on current volatility of 3.2%: low 0.78$, high 0.83$
Factors to consider:
- Earnings expected soon, date: 2026-01-02 bmo
Short-term LIMN quotes
Long-term LIMN plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $2.59MM | $2.91MM |
| Operating Income | $-2.59MM | $-2.91MM |
| Non-Operating Income | $1.39MM | $0.02MM |
| Interest Expense | $0.17MM | $0.14MM |
| R&D Expense | $3.76MM | $2.69MM |
| Income(Loss) | $-1.19MM | $-2.89MM |
| Taxes | $0.03MM | $0.02MM |
| Profit(Loss)* | $2.53MM | $-2.90MM |
| Stockholders Equity | $-10.69MM | $-15.87MM |
| Assets | $4.50MM | $2.83MM |
| Operating Cash Flow | $-3.35MM | $-3.11MM |
| Investing Cash Flow | $-0.82MM | $1.97MM |
| Financing Cash Flow | $-0.45MM | $1.05MM |
| Earnings Per Share** | $0.32 | $-0.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.